Borikova and colleagues reported a marked increase in total RhoA protein levels after the loss of expression of CCM1, CCM2, or CCM3 and demonstrated that knockdown of RhoA effectively reverses endothelial dysfunction caused by CCM deficiency (42). The gene discussed is RHOA; the disease is endothelial dysfunction.